MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$11,543,918
EPS
-$0.18
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative expenses
7,123,171
4,823,378
4,462,683*
3,078,378
Research and development
5,333,172
5,980,477
2,506,205*
4,584,131
Total operating expenses
12,456,343
10,803,855
6,968,888
7,662,509
Loss from operations
-12,456,343
-10,803,855
-6,968,888*
-7,662,509
Interest income
913,663
717,168
301,909
84,539
Total other income, net
913,663
717,168
301,909*
84,539
Loss before provision for income taxes
-11,542,680
-10,086,687
-6,666,979*
-7,577,970
Provision for income taxes
14,322
-
14,558*
7,722
Net loss
-
-
-6,681,537
-7,585,692
Net loss
-11,557,002
-10,086,687
-6,681,537*
-7,585,692
Unrealized (loss) gains on available-for-sale securities
-9,663
69,141
-
-
Foreign currency translation
22,747
-23,665
68,920
-2,568
Total other comprehensive income
13,084
45,476
68,920*
-2,568
Comprehensive loss
-11,543,918
-10,041,211
-6,612,617
-7,588,260
Basic EPS
-0.18
-0.18
-0.194
-0.24
Diluted EPS
-0.18
-0.18
-0.194
-0.24
Basic Average Shares
63,771,377
55,369,123
34,004,761
31,926,651
Diluted Average Shares
63,771,377
55,369,123
34,004,761
31,926,651
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Foreign currency
translation
$22,747
Comprehensive loss
-$11,543,918
Total other
comprehensive income
$13,084
Unrealized (loss) gains on
available-for-sale securities
-$9,663
Net loss
-$11,557,002
Interest income
$913,663
Loss before
provision for income taxes
-$11,542,680
Provision for income taxes
$14,322
Total other income,
net
$913,663
Loss from operations
-$12,456,343
Total operating
expenses
$12,456,343
General and
administrative expenses
$7,123,171
Research and development
$5,333,172
Buy us a coffee
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc. (IMMX)